These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Electron microscopic examination of basal lamina in Fukuyama congenital muscular dystrophy. Ishii H; Hayashi YK; Nonaka I; Arahata K Neuromuscul Disord; 1997 May; 7(3):191-7. PubMed ID: 9185184 [TBL] [Abstract][Full Text] [Related]
8. Deficiency of syntrophin, dystroglycan, and merosin in a female infant with a congenital muscular dystrophy phenotype lacking cysteine-rich and C-terminal domains of dystrophin. Tachi N; Ohya K; Chiba S; Matsuo M; Patria SY; Matsumura K Neurology; 1997 Aug; 49(2):579-83. PubMed ID: 9270600 [TBL] [Abstract][Full Text] [Related]
9. Massive muscle cell degeneration in the early stage of merosin-deficient congenital muscular dystrophy. Hayashi YK; Tezak Z; Momoi T; Nonaka I; Garcia CA; Hoffman EP; Arahata K Neuromuscul Disord; 2001 May; 11(4):350-9. PubMed ID: 11369186 [TBL] [Abstract][Full Text] [Related]
10. [Congenital muscular dystrophy with merosin deficiency: clinical, histopathological, immunocytochemical and genetic analysis]. Fardeau M; Tomé FM; Helbling-Leclerc A; Evangelista T; Ottolini A; Chevallay M; Barois A; Estournet B; Harpey JP; Fauré S; Guicheney P; Hillaire D Rev Neurol (Paris); 1996 Jan; 152(1):11-9. PubMed ID: 8729391 [TBL] [Abstract][Full Text] [Related]
14. Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy. Vachon PH; Xu H; Liu L; Loechel F; Hayashi Y; Arahata K; Reed JC; Wewer UM; Engvall E J Clin Invest; 1997 Oct; 100(7):1870-81. PubMed ID: 9312189 [TBL] [Abstract][Full Text] [Related]
15. Variable clinical phenotype in merosin-deficient congenital muscular dystrophy associated with differential immunolabelling of two fragments of the laminin alpha 2 chain. Sewry CA; Naom I; D'Alessandro M; Sorokin L; Bruno S; Wilson LA; Dubowitz V; Muntoni F Neuromuscul Disord; 1997 May; 7(3):169-75. PubMed ID: 9185180 [TBL] [Abstract][Full Text] [Related]
16. Clinical and histopathological study of merosin-deficient and merosin-positive congenital muscular dystrophy. Talim B; Kale G; Topaloglu H; Akçören Z; Caglar M; Gögüş S; Elkay M Pediatr Dev Pathol; 2000; 3(2):168-76. PubMed ID: 10679036 [TBL] [Abstract][Full Text] [Related]
17. Deficiency of a skeletal muscle isoform of alpha-actinin (alpha-actinin-3) in merosin-positive congenital muscular dystrophy. North KN; Beggs AH Neuromuscul Disord; 1996 Aug; 6(4):229-35. PubMed ID: 8887951 [TBL] [Abstract][Full Text] [Related]
18. Abnormal localization of laminin subunits in muscular dystrophies. Hayashi YK; Engvall E; Arikawa-Hirasawa E; Goto K; Koga R; Nonaka I; Sugita H; Arahata K J Neurol Sci; 1993 Oct; 119(1):53-64. PubMed ID: 8246011 [TBL] [Abstract][Full Text] [Related]
19. Brain alterations in the classical form of congenital muscular dystrophy. Clinical and neuroimaging follow-up of 12 cases and correlation with the expression of merosin in muscle. Trevisan CP; Martinello F; Ferruzza E; Fanin M; Chevallay M; Tomé FM Childs Nerv Syst; 1996 Oct; 12(10):604-10. PubMed ID: 8934020 [TBL] [Abstract][Full Text] [Related]
20. Deficiency of merosin (laminin M or alpha 2) in congenital muscular dystrophy associated with cerebral white matter alterations. Vainzof M; Marie SK; Reed UC; Schwartzman JS; Pavanello RC; Passos-Bueno MR; Zatz M Neuropediatrics; 1995 Dec; 26(6):293-7. PubMed ID: 8719743 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]